API reference
Carbocisteine
- CAS number
- 638-23-3
- Molecular formula
- C5H9NO4S
- Molecular weight
- 179.2 g/mol
About this molecule
Dyspnea and cough are common symptoms of chronic obstructive pulmonary disease (COPD) and other respiratory conditions characterized by increased mucus production. Individuals with COPD have a greater risk of pulmonary infection due to the growth and accumulation of viruses and bacteria in thick bronchial mucus. Carbocisteine is a mucolytic drug that alleviates respiratory symptoms and infections by reducing the viscosity of mucus, allowing it to be expelled. Several licenses for this drug were withdrawn following serious and fatal paradoxical effects after carbocisteine therapy in children; respiratory dress, dyspnea, and cough aggravation were reported by physicians in France and Italy. Carbocisteine is currently not FDA or Health Canada approved, but is approved for use in Asia, Europe, and South America.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- (2R)-2-amino-3-(carboxymethylsulfanyl)propanoic acid
- InChIKey
- GBFLZEXEOZUWRN-VKHMYHEASA-N
- SMILES
- C([C@@H](C(=O)O)N)SCC(=O)O
- Other CAS numbers recorded
- 186537-58-6 · 1391068-19-1
- PubChem CID
- 193653
Also known as
Carbocisteine · carbocysteine · S-Carboxymethyl-L-cysteine · S-(CARBOXYMETHYL)-L-CYSTEINE · carbocistein · Mucodyne · Rhinathiol · Transbronchin
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.